Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024:1451:219-237.
doi: 10.1007/978-3-031-57165-7_14.

Human Monkeypox Virus and Host Immunity: New Challenges in Diagnostics and Treatment Strategies

Shailendra Dwivedi  1 , Vijay Singh  2 , Ruchika Agrawal  3 , Radhieka Misra  4 , Sadashiv  5 , Ghizal Fatima  6 , Afroz Abidi  7 , Sanjeev Misra  8
Affiliations
Review

Human Monkeypox Virus and Host Immunity: New Challenges in Diagnostics and Treatment Strategies

Shailendra Dwivedi et al. Adv Exp Med Biol. 2024.

Abstract

The monkeypox virus (MPXV), responsible for human disease, has historically been limited to the African countries, with only a few isolated instances reported elsewhere in the world. Nevertheless, in recent years, there have been occurrences of monkeypox in regions where the disease is typically absent, which has garnered global interest. Within a period of less than four months, the incidence of MPXV infections has surged to over 48,000 cases, resulting in a total of 13 deaths. This chapter has addressed the genetics of the pox virus, specifically the human monkeypox virus, and its interaction with the immune systems of host organisms. The present chapter is skillfully constructed, encompassing diagnostic methodologies that span from traditional to developing molecular techniques. Furthermore, the chapter provides a succinct analysis of the therapeutic methods employed, potential future developments, and the various emerging difficulties encountered in illness management.

Keywords: Adaptive immunity; Diagnostics; Genomics; Host immunity; Human monkeypox virus; Innate immunity; Treatments.

PubMed Disclaimer

References

    1. Ali Y, Imtiaz H, Tahir MM et al (2023) Fragment-based approaches identified Tecovirimat-competitive novel drug candidate for targeting the F13 protein of the monkeypox virus. Viruses 15(2):570. https://doi.org/10.3390/v15020570 - DOI - PubMed - PMC
    1. Ando J, Ngo MC, Ando M et al (2020) Identification of protective T-cell antigens for smallpox vaccines. Cytotherapy 22(11):642–652 - DOI - PubMed - PMC
    1. Baker RO, Bray M, Huggins JW (2003) Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res 57(1–2):13–23 - DOI - PubMed - PMC
    1. Berthet N, Descorps-Declère S, Besombes C et al (2021) Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018. Sci Rep 11(1):13085. https://doi.org/10.1038/s41598-021-92315-8 - DOI - PubMed - PMC
    1. Bertran M, Andrews N, Davison C et al (2023) Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis S1473–3099(23):00057–00059. https://doi.org/10.1016/S1473-3099(23)00057-9 - DOI

LinkOut - more resources